Vitamin D Research Today is a free monthly online journal that collates and summarizes the latest research about Vitamin D, including details on sources, melanin, benefits, deficiency, supplements, calcium absorption.

Volume 4 (2007), Issue 2 (February)

1. Inhibition of lung carcinogenesis by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity.
   Int J Cancer, 120(7): 1402-9. [Abstract] [Full-text]
2. Vitamin D and outcomes in chronic kidney disease.
   Curr Opin Nephrol Hypertens, 16(2): 77-82. [Abstract] [Full-text]
3. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products.
   J Invest Dermatol, 127(3): 707-15. [Abstract] [Full-text]
4. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
   J Pharmacol Exp Ther, 320(3): 1119-26. [Abstract] [Full-text]
5. Intestinal resistance to 1,25 dihydroxyvitamin D in mice heterozygous for the vitamin D receptor knockout allele.
   Endocrinology, 148(3): 1396-402. [Abstract] [Full-text]
6. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
   J Clin Oncol, 25(6): 669-74. [Abstract] [Full-text]
7. Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer.
   Cancer Chemother Pharmacol, 59(5): 581-7. [Abstract] [Full-text]
8. Calcium/vitamin D supplementation and cardiovascular events.
   Circulation, 115(7): 846-54. [Abstract] [Full-text]
9. Role of Gln 85 of human CYP27A1 in 25-hydroxyvitamin D(3)-binding and protein folding.
   Biochem Biophys Res Commun, 355(1): 211-6. [Abstract] [Full-text]
10. Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
    Biopharm Drug Dispos, 28(2): 65-71. [Abstract] [Full-text]

© 2004-2008 Vitamin D Research Today. All Rights Reserved.